L
LabNow
Develops rapid, point-of-care diagnostic testing systems for in-vitro diagnostic applications
About LabNow
LabNow, founded in 2017 by Everson Cruz and Bárbara Paes, operates as a marketing technology firm with a sharp focus on performance-based customer acquisition for large-scale enterprises in Brazil.
The company's business model is centered around generating highly qualified sales leads, connecting its clients directly with prospective customers. This is executed on a Cost Per Lead (CPL) basis, ensuring clients pay for tangible results. LabNow specializes in serving sectors that rely on a consistent flow of new customers, such as healthcare, education, and industries with high-value product sales.
Utilizing a multi-channel digital strategy, LabNow leverages platforms like Google, Meta, and TikTok to capture potential consumer interest. The firm's core offering is enhanced by proprietary technology that includes a sophisticated lead scoring system. This system qualifies and ranks leads in real-time, filtering for the highest intent and quality before seamlessly integrating them into a client's Customer Relationship Management (CRM) software. This process provides sales teams with a steady stream of valuable and actionable opportunities.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Founded
- 2016
- Headquarters
- O'Fallon, United States
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Biotechnology, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | May 2010 | $605K | — | Undisclosed | — |
| DEBT✓Debt | Apr 2009 | $783K | — | Undisclosed | — |
Growth signals
Latest recorded traffic for LabNow is 270 monthly website visits, up 50% over the last three months. LabNow's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
George Soros
Austin Ventures
Sammons Enterprises
Other known investors1 additional known investor
Austin Technology Incubator
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about LabNow on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LabNow’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.